QR код

Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes

Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important role in the pathophysiology of diseases associated with chronic inflammation. We demonstrate that patients with type-2 diabetes have increased plasma levels of ANXA1 when compared to normoglycemic subj...

Повний опис

Збережено в:
Автори: Gareth S. D. Purvis, Massimo Collino, Rodrigo A. Loiola, Andrea Baragetti, Fausto Chiazza, Martina Brovelli, Madeeha H. Sheikh, Debora Collotta, Alessia Cento, Raffaella Mastrocola, Manuela Aragno, Juan C. Cutrin, Chris Reutelingsperger, Liliana Grigore, Alberico L. Catapano, Magdi M. Yaqoob, Giuseppe Danilo Norata, Egle Solito, Christoph Thiemermann
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2019-03-01
Серія:Frontiers in Immunology
Предмети:
type-2 diabetes
metabolism
Annexin A1
nephropathy
hepatosteatosis
Rho A
Онлайн доступ:https://www.frontiersin.org/article/10.3389/fimmu.2019.00571/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси